NDC 55758-300

OptimV Anti-Itch Maximum Strength

Benzocaine, Resorcinol

OptimV Anti-Itch Maximum Strength is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Pharmadel. The primary component is Benzocaine; Resorcinol.

Product ID55758-300_e064940f-83d8-85b6-e053-2995a90aec92
NDC55758-300
Product TypeHuman Otc Drug
Proprietary NameOptimV Anti-Itch Maximum Strength
Generic NameBenzocaine, Resorcinol
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2022-06-01
Marketing CategoryOTC MONOGRAPH NOT FINAL /
Application Numberpart348
Labeler NamePharmadel
Substance NameBENZOCAINE; RESORCINOL
Active Ingredient Strength20 g/100g; g/100g
Pharm ClassesAllergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 55758-300-07

1 TUBE in 1 CARTON (55758-300-07) > 20 g in 1 TUBE
Marketing Start Date2022-06-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "OptimV Anti-Itch Maximum Strength" or generic name "Benzocaine, Resorcinol"

NDCBrand NameGeneric Name
0363-0673Anti ItchBenzocaine, Resorcinol
0113-7142basic care vagicaineBenzocaine, Resorcinol
55621-014Family WellnessBENZOCAINE, RESORCINOL
55621-016Family WellnessBENZOCAINE, RESORCINOL
63868-949Feminine Anti-Itch CremeBENZOCAINE, RESORCINOL
46122-576good neighbor pharmacy vagicaineBenzocaine, Resorcinol
0113-0142good sense vagicaineBenzocaine, Resorcinol
49738-269Image Essentials VagicaineBenzocaine, Resorcinol
55758-300OptimV Anti-ItchBenzocaine, Resorcinol
21130-142signature care vagicaineBenzocaine, Resorcinol
49738-142smart sense vagicaineBenzocaine, Resorcinol
36800-142topcare vagicaineBenzocaine, Resorcinol
11673-142Up and up vagicaineBenzocaine, Resorcinol
76466-010VAGI-CURE (MAXIMUM STRENGTH)BENZOCAINE, RESORCINOL
29500-7820VagicaineBENZOCAINE, RESORCINOL
41250-142VagicaineBenzocaine, Resorcinol
59779-588Vagicaine Maximum Strength Anti-Itch CreamBenzocaine, Resorcinol

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.